These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22945792)

  • 1. A probable clinically significant interaction between warfarin and cloxacillin: three case reports.
    Khalili H; Nikvarz N; Najmeddin F; Dashti-Khavidaki S
    Eur J Clin Pharmacol; 2013 Mar; 69(3):721-4. PubMed ID: 22945792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-dimer to guide the intensity of anticoagulation in Chinese patients after mechanical heart valve replacement: a randomized controlled trial.
    Zhang L; Zheng X; Long Y; Wu M; Chen Y; Yang J; Liu Z; Zhang Z
    J Thromb Haemost; 2017 Oct; 15(10):1934-1941. PubMed ID: 28762606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal INR level for warfarin therapy after mechanical mitral valve replacement.
    Kamthornthanakarn I; Krittayaphong R
    BMC Cardiovasc Disord; 2019 Apr; 19(1):97. PubMed ID: 31023235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A significant interaction between moxifloxacin and warfarin in a patient with a mitral bioprosthetic valve.
    Yildiz F; Kurtaran B; Cayli M; Candevir A; Sümbül Z
    Heart Vessels; 2008 Jul; 23(4):286-8. PubMed ID: 18649061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition from acenocoumarol to warfarin in a 12-year-old child.
    Hakacova N; Björkhem G; Hanséus K
    Congenit Heart Dis; 2011; 6(6):661-4. PubMed ID: 21501391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenously administered cloxacillin-induced neutropenia with eosinophilia in a patient with infective endocarditis: a case report.
    Jayaweera JAAS; Abeydeera WPH; Ranasinghe GR
    J Med Case Rep; 2018 Dec; 12(1):384. PubMed ID: 30593283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation early after mechanical valve replacement: improved management with patient self-testing.
    Thompson JL; Burkhart HM; Daly RC; Dearani JA; Joyce LD; Suri RM; Schaff HV
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):599-604. PubMed ID: 22921821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloxacillin induced agranulocytosis: A rare adverse event of a commonly used antibiotic.
    Mani SSR; Iyyadurai R
    Int J Immunopathol Pharmacol; 2017 Sep; 30(3):297-301. PubMed ID: 28786715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose intravenous flucloxacillin may affect warfarin therapy.
    Choi PY; Phillips KL; Rae I
    Med J Aust; 2011 Jun; 194(11):613. PubMed ID: 21644882
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic resistance to warfarin therapy masked by amiodarone in a 2-year-old girl with mitral valve replacement.
    Moreau C; Bajolle F; Siguret V; Loriot MA; Bonnet D
    J Thromb Haemost; 2013 Mar; 11(3):555-72. PubMed ID: 23241284
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of gene polymorphims on the warfarin treatment at initial stage.
    Liu J; Jiang HH; Wu DK; Zhou YX; Ye HM; Li X; Luo ZY; Guo Z; Zhang YL; Wang YC; Zhang W; Zhou HH; Wang LS
    Pharmacogenomics J; 2017 Jan; 17(1):47-52. PubMed ID: 26644206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced anticoagulant effect of warfarin in a patient treated with cloxacillin.
    Marusic S; Gojo-Tomic N; Bacic-Vrca V; Franic M
    Int J Clin Pharmacol Ther; 2012 Jun; 50(6):431-3. PubMed ID: 22677303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of UDP-Glucuronosyltransferase Polymorphisms on Stable Warfarin Doses in Patients with Mechanical Cardiac Valves.
    An SH; Chang BC; Lee KE; Gwak HS
    Cardiovasc Ther; 2015 Dec; 33(6):324-8. PubMed ID: 26223945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aniticoagulation in patients following prosthetic heart valve replacement.
    Akhtar RP; Abid AR; Zafar H; Khan JS
    Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):10-7. PubMed ID: 19262444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin use and dose adjustment in a patient with mitral valve replacement.
    Yuan SM
    Pak J Pharm Sci; 2015 Jul; 28(4):1351-5. PubMed ID: 26142525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of warfarin in paediatric patients with prosthetic cardiac valves: a retrospective audit.
    Wong CS; Batchelor K; Bua J; Newall F
    Thromb Res; 2011 Oct; 128(4):331-4. PubMed ID: 21620442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin-induced skin necrosis and heparin-induced thrombocytopenia following mitral valve replacement for marantic endocarditis.
    White CA; Chung DA; Thomas M; Marrinan MT
    J Heart Valve Dis; 2006 Sep; 15(5):716-8. PubMed ID: 17044380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Khat Chewing Effect on the International Normalized Ratio in Patients with Mechanical Heart Valves under Warfarin Therapy.
    Abdulwadoud Alshoabi S; Noman Aljaber N; Omer Hussain A; Mohammed Aloufi K; Gafar Salih S
    Pak J Biol Sci; 2020 Jan; 23(11):1487-1491. PubMed ID: 33274879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of anticoagulation following bioprosthetic valve implantation: observations from ANSWER.
    Brennan JM; Alexander KP; Wallace A; Hodges AB; Laschinger JC; Jones KW; O'Brien S; Webb LE; Dokholyan RS; Peterson ED
    J Heart Valve Dis; 2012 Jan; 21(1):78-87. PubMed ID: 22474747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capecitabine-warfarin interaction.
    Janney LM; Waterbury NV
    Ann Pharmacother; 2005 Sep; 39(9):1546-51. PubMed ID: 16014372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.